drugset / Trial / NCT06795165

Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

NCT06795165

Phase 4 Completed 24 enrolled Eye Research Foundation, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Timeline

Start
2025-02-02
Primary completion
2025-04-28
Completion
2025-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxidectin Other / unclassified 2 mg Oral

Indications